Hunan University of Traditional Chinese Medicine   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Changsha China (1960)

Organization Overview

First Clinical Trial
2011
NCT01978730
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hunan Academy of Traditional Chinese Medicine Affiliated Hospital | Hunan University of Chinese Medicine | the chief of the neurology department, First Hospital of Hunan University of Chinese Traditional Medicine | The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine | The First Hospital of Hunan University of Chinese Medicine | The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 2)

Angina, Stable (Phase 2)

Blind Loop Syndrome (Phase 2)

Cerebral Infarction (Phase 4)

Coronary Artery Disease (Phase 2)

Dementia (Phase 2)

Dementia, Vascular (Phase 2)

Influenza, Human (Phase 4)

Ischemia (Phase 4)

Peripheral Nervous System Diseases (Phase 2)

Precancerous Conditions (Phase 2)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 16